Skip to main content
. Author manuscript; available in PMC: 2015 Jun 24.
Published in final edited form as: Prostate. 2013 Nov 28;74(4):359–364. doi: 10.1002/pros.22755

TABLE III.

Associations Between Age-Adjusted Telomere Length and Prostate Cancer, Stratified by Timing of Blood Draw Relative to Diagnosis, Johns Hopkins Hereditary Prostate Cancer Family Database

TL quartilea No. of affected men No. of unaffected men ORb 95% CI P-value
Affected men with blood drawn before or within a year of diagnosis and all unaffected men
 Q1 15 16 2.26 (0.40, 12.64) 0.35
 Q2 2 16 0.38 (0.06, 2.57) 0.32
 Q3 7 15 0.66 (0.12, 3.67) 0.63
 Q4 15 16 1.00
P-trend 0.45
 Q1 15 16 3.55 (0.82, 15.43) 0.09
 Q2–Q4 24 47 1.00
Affected men with blood drawn after diagnosis and all unaffected men
 Q1 23 16 0.34 (0.09, 1.33) 0.12
 Q2 14 16 0.64 (0.18, 2.28) 0.49
 Q3 14 15 0.70 (0.20, 2.42) 0.57
 Q4 22 16 1.00
P-trend 0.14
 Q1 23 16 0.44 (0.13, 1.45) 0.17
 Q2–Q4 50 47 1.00
a

Quartiles are based on batch-specific cut-points derived from the distribution of age-adjusted telomere length in unaffected men.

b

ORs are adjusted for age and decade of birth and account for clustering by family.